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Ultrasound-guided percutaneous endovascular
aneurysm repair success is predicted by access
vessel diameter
Rodney P. Bensley, MD, Rob Hurks, MD, Zhen Huang, MD, Frank Pomposelli, MD,
Allen Hamdan, MD, Mark Wyers, MD, Elliot Chaikof, MD, and Marc L. Schermerhorn, MD, Boston,
Mass
Objective: Ultrasound scan-guided access allows for direct visualization of the access artery during percutaneous
endovascular aortic aneurysm repair. We hypothesized that the use of ultrasound scan guidance allowed us to safely
increase the utilization of percutaneous endovascular aortic aneurysm repair to almost all patients and decrease access
complications.
Methods: A retrospective chart review of all elective endovascular aortic aneurysm repairs, both abdominal and descending
thoracic, from 2005 to 2010 was performed. Patients were identified using International Classification of Disease, 9th
Revision, Clinical Modification Codes and stratified based on access type: percutaneous vs cut-down. We examined the
success rate of percutaneous access and the cause of failure. Sheath size was large (18-24F) or small (12-16F). Minimum
access vessel diameter was also measured. Outcomes were wound complications (infections or clinically significant
hematomas that delayed discharge or required transfusion), operative and incision time, length of stay, and discharge
disposition. Predictors of percutaneous failure were identified.
Results:One hundred sixty-eight patients (296 arteries) had percutaneous access endovascular aneurysm repair (P-EVAR)
whereas 131 patients (226 arteries) had femoral cutdown access EVAR. Ultrasound scan-guided access was introduced
in 2007. P-EVAR increased from zero cases in 2005 to 92.3% of all elective cases in 2010. The success rate with
percutaneous access was 96%. Failures requiring open surgical repair of the artery included seven for hemorrhage and six
for flow-limiting stenosis or occlusion of the femoral artery. P-EVAR had fewer wound complications (0.7% vs 7.4%;
P .001), shorter operative time (153.3 vs 201.5 minutes; P< .001), and larger minimal access vessel diameter (6.7 mm
vs 6.1 mm; P< .01). Patients with failed percutaneous access had smaller minimal access vessel diameters when compared
to successful P-EVAR (4.9 mm vs 6.8 mm; P < .001). More failures occurred in small sheaths than large ones (7.4% vs
1.9%; P .02). Access vessel diameter<5mm is predictive of percutaneous failure (16.7% of vessels<5mm failed vs 2.4%
of vessels >5 mm failed; P < .001; odds ratio, 7.3; 95% confidence interval, 1.58-33.8; P  .01).
Conclusions:Ultrasound scan-guided P-EVAR can be performed in the vast majority of patients with a high success rate,
shorter operative times, and fewer wound complications. Access vessel diameters <5 mm are at greater risk for
percutaneous failure and should be treated selectively. ( J Vasc Surg 2012;55:1554-61.)
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aEndovascular aortic aneurysm repair (EVAR) has re-
placed open surgical repair as the preferred method for
treating anatomically suitable infrarenal abdominal aortic an-
eurysms (AAAs) and descending thoracic aortic aneurysms
in the elective setting.1 Endovascular repair requires the
From the Department of Vascular and Endovascular Surgery, Beth Israel
Deaconess Medical Center and Harvard Medical School, Boston, Mass.
This work was supported by the National Institutes of Health (NIH) T32
Harvard-Longwood Research Training in Vascular Surgery grant
HL007734.
Author conflict of interest: Dr Schermerhorn declares that he is affiliated
with the Endologix Data Safety and Monitoring Board and is a Medtronic
consultant. Drs Hamdan and Wyers are also on the Data Safety and
Monitoring Board for Endologix.
Presented at the Thirty-eighth Annual Meeting of the New England Society
for Vascular Surgery, Providence, RI, September 16, 2011; plenary pre-
sentation.
Reprint requests: Marc L. Schermerhorn, MD, 110 Francis Street, Suite 5B,
Boston, MA 02215 (e-mail: mscherm@bidmc.harvard.edu).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a conflict of interest.
0741-5214/$36.00a
Copyright © 2012 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.12.042
1554lacement of large-diameter sheaths into the common
emoral arteries (CFAs) for stent graft deployment. Ac-
ess to the CFA has typically been achieved by open
emoral cutdown incisions. Complications related to
emoral cutdown include wound infections, lymphoce-
es, and hematomas. With the development of suture-
ediated closure devices and the “Preclose” technique2
or closure of large femoral arteriotomies, some vascular
urgeons are now performing percutaneous endovascular
neurysm repair (P-EVAR). Among prior reports includ-
ng 50 or more patients, the technical success rates of
ercutaneous access have ranged between 76% and
6%.3-7 The utilization of ultrasound scan guidance has
een suggested to improve accuracy and lower the com-
lication rate associated with percutaneous access.7,8
Several patient factors have been stated to be relative
ontraindications for percutaneous arteriotomy closure.
ome studies have demonstrated that morbid obesity
body mass index [BMI]35), femoral artery calcification,
roin scars from prior interventions, and large sheath size
re more commonly associated with percutaneous failure
nd wound complications.3,9-15 Other studies have dem-
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Volume 55, Number 6 Bensley et al 1555onstrated no association between sheath size, morbid obe-
sity, and femoral artery calcification with percutaneous
failure and wound complications.7,16,17 Percutaneous ac-
cess has been suggested to decrease operating room time as
well as patient length of stay (LOS) in the hospital.9,11
The majority of the data are from single-institution case
series and small single-center randomized trials where pa-
tients had percutaneous access in one limb and femoral
cutdown access in the contralateral limb. Our study is the
first to group patients into purely percutaneous access,
purely femoral cutdown access, or both. The purpose of
this study was to describe our experience with P-EVAR and
to compare our outcomes with the published literature.
METHODS
Overview. We performed a retrospective study of all
elective EVARs (abdominal and thoracic) from January 1,
2005, to December 31, 2010, at a single tertiary care
medical center. Patients were stratified based on their type
of access for stent graft delivery: P-EVAR vs femoral cut-
down access endovascular aneurysm repair (C-EVAR).
Only limbs accessed with a 12F sheath size or larger were
included in the study. Sheaths were categorized as small
(12-16F) or large (18-24F). The majority of cases were
performed in an operating room endovascular suite with
fixed imaging and most patients received general anesthe-
sia. All patients were anticoagulated with heparin during
the procedure and received protamine reversal at the end of
the case. Patients were seen for follow-up typically at 1
month where each CFA puncture site and cutdown incision
was assessed via clinical examination. A pulse examination
was performed as well as a history taken to identify symp-
toms of claudication. A computed tomography (CT) scan is
obtained that goes through the femoral heads to evaluate
the femoral artery access site. Demographic data were
recorded as well as BMI. Intraoperative variables analyzed
included sheath size and minimum access vessel diameter.
Minimum access vessel diameter was measured by CT scan
and is the minimum intraluminal diameter of the CFA or
external iliac artery as determined by the Patient Evaluation
and Management System.
Outcome measures evaluated were technical success
rate of percutaneous access, conversion to open femoral
artery repair, cause of percutaneous failure, LOS, discharge
disposition, and wound complications. Technical success
was defined as a successful arterial closure without the need
for conversion to open femoral artery repair as well as no
change in the patient’s baseline pulse examination. Percutane-
ous failures were due to either hemorrhage or flow-limiting
stenosis or occlusion of the CFA. Hemorrhage was de-
fined as persistent bleeding or an expanding hematoma
that required surgical exploration after tying the Perclose
sutures. Flow limitation was identified immediately in
the operating room based on a change in the patient’s
baseline pulse examination at the end of the procedure or
at the 1-month follow-up visit if the patient had symp-
toms of claudication or a change in his or her pulse
examination. Operating room time (time from entry into the operating room until discharge to the recovery
oom) and incision time (time from initial groin punc-
ure or skin incision to skin closure or completion of
anual compression) were measured as well. Operating
oom and incision time were compared only in aneurysm
epairs without concomitant procedures such as hypo-
astric coiling and renal and iliac stents. Wound compli-
ations included wound infections requiring antibiotic
reatment, seromas, pseudoaneurysms, and clinically sig-
ificant hematomas that delayed routine discharge from
he hospital or required transfusion. This study was
pproved by the Institutional Review Board at Beth
srael Deaconess Medical Center and Harvard Medical
chool.
Statistical analysis. We calculated the total number of
atients and arteries that underwent percutaneous or fem-
ral cutdown access and how the proportion of each has
hanged over time. Analyses of mean sheath size, propor-
ion of sheaths that were large (18-24F), and technical
uccess of percutaneous access were performed on a per-
imb basis. Analyses of wound complications and other
utcomes were calculated on a per-patient basis. Preoper-
tive characteristics and outcomes were reported as propor-
ions of the sample and median with interquartile range.
OS was reported as both mean  SD as well as median
ith interquartile range. Patient variables were compared
sing univariate analysis. Categorical variables were ana-
yzed using 2 and the Fisher exact test where appropriate.
ontinuous variables were compared using the Wilcoxon
ank-sum test. A test of trend over time was used to test for
ignificance in changes in the minimum access vessel diam-
ter in patients who received P-EVAR over the study pe-
iod. Multivariable logistic regression was used to identify
redictors of percutaneous failure. Statistical significance
as defined as P  .05. All statistical tests were performed
sing Stata 12 software (StataCorp, College Station, Tex).
Patient selection. Early in our experience, the deci-
ion to perform EVAR via percutaneous access varied by
he attending physician. Percutaneous access was initially
erformed on the contralateral 12F side when deploying
he Gore Excluder stent graft (W. L. Gore and Associates,
lagstaff, Ariz). Percutaneous access was generally avoided
n patients with small arteries and femoral artery calcifica-
ion in our early experience. Ultrasound scan guidance for
ercutaneous access was introduced and routinely used
eginning in 2007. As our experience broadened with the
tilization of ultrasound scan guidance, patient selection
or percutaneous access expanded rapidly, and now virtually
very elective EVAR is performed with percutaneous ac-
ess.
Preclose technique. All patients receive preoperative
ntravenous antibiotics. After sterile drapes are placed, the
ltrasound probe is used to identify the CFA and the
emoral bifurcation in all patients. The best location for
FA puncture is determined by the extent of calcification
n the anterior wall and plaque both anteriorly and poste-
iorly. A small stab incision is made in the skin inferior to
he expected arterial puncture site. Blunt dissection with a
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tissue to the anterior wall of the CFA under ultrasound scan
guidance. A micropuncture needle is inserted into the CFA
under direct visualization with the ultrasound probe. Flu-
oroscopy is used to confirm puncture over the femoral
head. A microsheath and 0.035-inch wire are inserted into
the CFA followed by a 7F dilator. After dilation of the
artery and subcutaneous tissue, a 6F Perclose Proglide
device (Abbott Vascular, Redwood City, Calif) is inserted
over the wire into the CFA. Pulsatile blood flow from the
marker lumen confirms proper positioning of the Proglide
device within the CFA. The Proglide device is then fired
and the wire is replaced before the device is withdrawn from
the CFA. The sutures are not tied down as they are secured
to the sterile drapes with a Kelly clamp. A second Proglide
device is inserted into the same artery over the wire, con-
firmation of intra-arterial placement is obtained, the wire is
removed, the device is fired, the wire is then replaced, and
the sutures are secured with a Crile clamp to distinguish the
second knot from the first. A 7F 25-cm sheath is then
inserted into the CFA. The above steps are repeated on the
contralateral groin leaving two sets of untied Proglide
sutures in each groin. Initially, we deployed the two devices
at 10 and 2 o’clock and changed over time to 11 and 1
o’clock and currently aim for 11:59 and 12:01 with the goal
of slightly offsetting the devices without puncturing the
side wall of the CFA to avoid narrowing the vessel or failure
to puncture the vessel wall. The patient is then heparinized.
If there is hemorrhage around the 7F sheath, a 12F sheath
is inserted over an Amplatz or Lunderquist wire. Serial
dilations are used with Coons dilators before placement of
the large sheath and device.
Standard EVAR then commences. The majority of the
stent grafts placed at our institution during the study period
were Gore and Zenith (Cook, Bloomington, Ind) stent
grafts. In general, we deliver the main body through the
larger access vessel. At the completion of the operation, the
previously placed Perclose sutures are irrigated to remove
any debris that may be present. It is important to maintain
wire access until hemostasis is ensured. Initially, we used a
floppy guidewire, but now we use a Benstson wire. We
prefer to avoid a stiff wire as this may hamper hemostasis
with the initial knot. Gentle manual pressure is applied to
the proximal CFA as the sheath is removed over a wire.
After removal of the sheath, manual pressure is released to
allow the knot pusher to advance properly through the
subcutaneous tissue and cinch down the preformed knot of
the Perclose suture. If hemostasis is adequate after tying of
the first Perclose suture, the wire is removed and the suture
is locked and cut. The second suture is then tied down,
locked, and cut. Manual pressure is then held for approxi-
mately 5 minutes. If hemostasis is inadequate after tying the
first knot, a third Perclose device is inserted over the wire
and deployed, and this usually results in adequate hemosta-
sis. If hemostasis is still not achieved, a fourth Perclose
device may be deployed or a 7F sheath may be introduced
over the wire to provide hemostasis while the CFA is
surgically explored (this can be upsized to a 12F sheath or carger as needed). The pedal pulses are always checked at
he end of the operation and compared to the preoperative
ulse examination. Duplex scan examination of the punc-
ure site may be performed to assess the patency of the
emoral vessels. In our series, initially, a duplex scan exam-
nation was never performed, but now it is performed
electively. All patients with a groin hematoma receive
anual compression followed by a duplex scan examina-
ion to evaluate for ongoing hemorrhage or pseudoaneu-
ysm. If a patient has no palpable pulses preoperatively, a
uplex scan examination should be performed because it
ay affect the decision making regarding open surgical
epair of the femoral artery. If pulses are lost or the duplex
can examination shows significant stenosis, the ipsilateral
roin is then explored surgically.
ESULTS
We identified 294 patients who underwent elective
VAR between 2005 and 2010 at our institution; 267 had
AAs and 27 had descending thoracic aortic aneurysms.
ne hundred sixty-three patients underwent percutaneous
ccess (P-EVAR) whereas 126 underwent femoral cutdown
ccess (C-EVAR). Five patients had combined access with
ne groin accessed via percutaneous technique and the
ther accessed via cutdown. Only limbs accessed with 12F
heaths or larger were evaluated: 168 patients (296 arteries)
nderwent P-EVAR and 131 patients (226 arteries) under-
ent C-EVAR. Sheath size was similar between P-EVAR
nd C-EVAR procedures (17.0 2.0F vs 17.2 1.5F; P
58). Similarly, the proportion of sheaths that were consid-
red large (18-24F) was similar between P-EVAR and
-EVAR procedures (54.1% vs 60.6%; P  .13). A third
erclose device was needed in 59 of 296 arteries (19.9%).
ix of the 59 additional Perclose devices failed to achieve
emostasis (10.2%). A fourth Perclose device was placed in
wo of these arteries (0.7%) and both of these were success-
ul in achieving hemostasis. The remaining four arteries
nderwent conversion to open surgical repair. We experi-
nced no problems passing the third and fourth Perclose
evices through the arteriotomy.
Percutaneous vs cutdown. We performed zero per-
ig 1. Proportion of percutaneous endovascular aneurysm repair
P-EVAR) over time from 2005 to 2010. C-EVAR, Cutdown
ccess endovascular aneurysm repair.utaneous repairs in 2005 and two in 2006 (6.7% of all
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Volume 55, Number 6 Bensley et al 1557endovascular repairs in 2006). After the introduction of
ultrasound scans in 2007, the proportion of cases per-
formed via percutaneous access increased from 39.3% in
2007 to 92.3% in 2010 (Fig 1). Four of the five femoral
cutdowns performed in 2010 were for planned femoral-
femoral bypasses in patients with severe occlusive disease of
one of their iliac arteries, whereas the remaining femoral
cutdown was performed in a patient with distal emboliza-
tion of debris from the aneurysm sac. Femoral cutdown was
performed in this patient to isolate the femoral vessels and
prevent further lower extremity embolization during wire
manipulation and stent graft delivery.
Demographic and comorbidities. The majority of
patients were white men with a similar mean age in the
P-EVAR and C-EVAR groups (75.0 years vs 75.7 years;
Table I). Comorbidities were similar between the P-EVAR
and C-EVAR groups. The only significant differences were
a higher rate of hypertension and hyperlipidemia in the
P-EVAR group. Mean BMI was similar (27.0 vs 26.7) as
well as the proportion of obese patients with BMI 30
(28.2% vs 19.4%). The proportion of patients with prior
groin operations was 6.8% in the P-EVAR group vs 11.1%
in the C-EVAR group.
Minimum access vessel diameter. The minimum ac-
cess vessel diameter was significantly larger in the P-EVAR
group (6.7 mm vs 6.1 mm; P  .01). The change in
minimum vessel diameter over time in arteries undergoing
P-EVAR is shown in Fig 2. The mean diameter was 7.3 mm
in 2006 and this decreased by over 1 mm to 6.2 mm in
Table I. Demographics and comorbidities of patients
undergoing P-EVAR or C-EVAR from 2005 to 2010
P-EVAR C-EVAR
Men 81.0% 77.0%
Age (mean) 75.0  8.8 75.7  8.9
White race 85.9% 89.7%
Coronary artery disease 45.4% 43.7%
Myocardial infarction 25.2% 27.0%
Percutaneous coronary
intervention
17.2% 13.5%
Coronary artery bypass graft 19.0% 21.4%
Hypertension 82.8% 69.1%
Atrial fibrillation 15.3% 19.8%
Valvular heart disease 8.0% 12.7%
Congestive heart failure 7.4% 11.9%
Hyperlipidemia 74.2% 57.9%
Diabetes 19.6% 22.2%
Renal insufficiency 19.0% 23.8%
COPD 25.2% 31.8%
Stroke 11.7% 10.3%
Peripheral vascular disease 19.6% 19.1%
BMI (mean) 27.0  5.3 26.7  5.7
BMI 30 (obese) 28.2% 19.4%
Prior groin operation 6.8% 11.1%
Minimum access vessel
diameter
6.7  1.6 mm 6.1  1.4 mm
BMI, Body mass index; C-EVAR, cutdown access endovascular aneurysm
repair; COPD, chronic obstructive pulmonary disease; P-EVAR, percutane-
ous endovascular aneurysm repair.2010 (P  .01; test of trend). oPercutaneous failure. There were 13 percutaneous
ailures (12 patients) in 296 arteries requiring conversion to
pen surgical exploration and repair of the artery, giving a
echnical success rate of 96% (93% success rate per patient).
leven failures were noted immediately in the operating
oom at the conclusion of the case, one failure occurred 12
ours postoperatively when the patient was on the vascular
ard, and one failure was discovered on postoperative day
0 at the patient’s follow-up clinic visit (Table II). Fig 3 is
preoperative CT angiogram with three-dimensional re-
onstruction of a patient with extensive plaque burden in
he right common femoral/external iliac artery who expe-
ienced percutaneous failure. This patient was noted to
ave no pedal pulses at the end of the operation and after
pen surgical exploration, the patient was noted to have a
laque disruption from the Perclose device causing signifi-
ant flow-limiting stenosis.
A greater proportion of women experienced failure
ompared to men, but this was not significant (12.5% vs
.9%; P  .18). One failure occurred in an obese patient
nd one occurred in a patient with groin scar tissue. Fig 4
hows the absolute number of arteries per millimeter of size
long the left vertical axis (48 diameters are missing) and
he proportion of arteries that failed percutaneous access
er millimeter of size along the right vertical axis (one
iameter is missing). The majority of the access vessels in
P-EVAR Mean Vessel Diameter
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ig 2. Change in percutaneous endovascular aneurysm repair
P-EVAR) minimum access vessel diameter over time from 2006
o 2010.
able II. Causes of percutaneous failure requiring open
urgical repair
emostasis
ear in anterior arterial wall
isrupted plaque
ive failed Perclose deployments
uture tied in subcutaneous tissue
Two failures due to calcification
One failure due to scar tissue
One failure due to unknown cause
low-limiting stenosis
ive disrupted plaques
hrombosis due to posterior intimal damageur study had minimum diameters between 5 and 8.9 mm
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June 20121558 Bensley et al(78.2%), whereas a small amount (4.8%) were larger vessels
(9 mm), and the remaining 16.9% were small vessels
between 3 and 4.9 mm. The percutaneous failure rate was
16.7% for all access vessels5 mm, 6.3% for vessels 5 to 5.9
mm, 2.1% for vessels 6 to 8.9 mm, and 0% in vessels 9
mm. The minimum access vessel diameter was significantly
smaller in patients who failed percutaneous access (4.9 mm
vs 6.8 mm; P  .001). Most failures (58.3%) in our study
occurred in arteries smaller than 5 mm. Fig 5 shows the
absolute number of sheaths per French size along the left
vertical axis and the proportion of failures per sheath size
along the right vertical axis. More failures occurred in small
sheaths than large ones (7.4% vs 1.9%; P  .02). Percuta-
neous failures have decreased over time: 9.1% in 2007, 6.8%
in 2009, and 2.7% in 2010 (there were zero failures in
2008). The decrease in percutaneous failures occurred de-
spite a greater proportion of smaller arteries (5 mm)
being treated over time: 0% of arteries were 5 mm in
Fig 3. Preoperative computed tomography (CT) angiog
with heavy plaque burden in the right common femoral an
Fig 4. Minimum access vessel diameter in millimeters (horizontal
axis) with the absolute number of treated arteries within each
access vessel diameter (left axis) and the proportion of arteries with
percutaneous failure within each access vessel diameter (right axis).2007, 8.0% in 2008, 15.8% in 2009, and 21.7% in 2010. iPostoperative outcomes. There were no deaths.
ore patients who underwent P-EVAR were discharged
ome (91.2% vs 84.4%; P  .11). Mean LOS was 1 day
horter in patients who underwent P-EVAR, which exhib-
ted a trend toward significance (3.1 days vs 4.1 days; P 
08). Median LOS was similar (2 days [1-3] vs 2 days
2-4]). Sixteen patients who underwent P-EVAR and 31
atients with C-EVAR had no 30-day follow-up and were
xcluded from the analysis of wound complications. There
as one wound complication (0.7%) in the P-EVAR group
hematoma that delayed discharge) and seven wound com-
lications (7.4%) in the C-EVAR group (three wound
nfections, two hematomas that delayed discharge, one
seudoaneurysm, and one seroma); P  .01. Sixteen pa-
ients had longitudinal cutdown incisions and 52 had
blique incisions. The remaining patients did not have
ufficient documentation to determine incision orientation.
he wound complication rate was 6.3% with longitudinal
ith three-dimensional reconstruction showing a patient
ernal iliac arteries who experienced percutaneous failure.
ig 5. Sheath size (horizontal axis) with the absolute number of
heaths per French size (left axis) and the proportion of percuta-
eous failures per sheath size (right axis).ram wncisions and 10.9% with oblique incisions. There were no
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taneous access.
Operating room and incision time. When examin-
ing straightforward EVAR cases only (excluding patients
with concomitant procedures such as hypogastric emboli-
zation [n 11] and renal [n 6] or iliac stents [n 11] for
stenosis), percutaneous access significantly reduced total
operating room time and incision time when compared to
femoral cutdown access: operating room time (143 [126-
173] minutes vs 196 [178-214] minutes; P  .001) and
incision time (90 [72-109] minutes vs 133 [116-153]
minutes; P .001). Failed percutaneous access negated the
reduction in operating room and incision times when com-
pared to patients with successful percutaneous access: op-
erating room time (197 [169-269] minutes vs 141 [125-
170] minutes; P .001) and incision time (147 [115-212]
minutes vs 89 [72-107] minutes; P  .001). Failed P-
EVAR operating room and incision times were longer than
C-EVAR, but this was not significant.
Predictors of percutaneous failure. Multivariable lo-
gistic regression was performed to identify predictors of
percutaneous failure. Due to the low rate of percutaneous
failures (n  13), a limited multivariable model was run.
After controlling for age, female gender, and the presence
of peripheral vascular disease (any patient with a diagnosis
of claudication or a history of lower extremity angioplasty,
stenting, or bypass), small vessel size (5 mm, dichoto-
mous variable) is predictive of percutaneous failure (odds
ratio, 7.3; 95% confidence interval, 1.58-33.8; P  .01).
DISCUSSION
We observed a high technical success rate with ultra-
sound scan-guided percutaneous access and found that
minimum access vessel diameter rather than sheath size
predicts failure. In our experience, we started simple, and,
as we gained experience and familiarity with percutaneous
access, we expanded this technique to virtually all patients.
In addition to experience, we feel that ultrasound scan
guidance has allowed us to improve our technical success
rate by allowing us to more accurately puncture the CFA,
rather than the superficial femoral or profunda femoris
arteries, and to find the best puncture site on the CFA,
avoiding areas with anterior calcification or plaque if pres-
ent. Our study is the first to incorporate the minimum
access vessel diameter as a potential predictor of percutane-
ous failure and found this to be the only predictor of failure
even with large 24F sheaths.
The majority of the access vessels in our study had
minimum diameters between 5 and 8.9 mm (78.3%),
whereas a small amount (4.8%) were larger vessels (9
mm), and the remaining 16.9% were small vessels between
3 and 4.9 mm. As we have expanded P-EVAR to nearly all
patients who present for elective AAA repair, it is of no
surprise that the minimum access vessel diameter of pa-
tients undergoing P-EVAR has decreased over time from a
mean size of 7.3 mm in 2006 to a mean size of 6.2 mm in
2010 (P  .01). Of the 12 percutaneous failures with
documented minimum vessel diameters, seven (58.3%) tere in vessels smaller than 5 mm (16.7% of all vessels 5
m failed compared to 2.4% of all vessels 5 mm). The
inimum access vessel diameter was significantly smaller in
atients who failed percutaneous access (4.9 mm vs 6.8
m; P .001). Women typically have smaller arteries than
en, and a greater proportion of women in our study
xperienced percutaneous failure when compared to men
12.5% vs 5.9%; P  .19), but this was not significant.
hen performing multivariable logistic regression and
ontrolling for age and gender, access vessel size 5 mm
as the only predictor of percutaneous failure. This does
ot mean that patients with small access vessels should not
e offered percutaneous repair, but rather that care must be
xercised when deciding which small vessels upon which to
ttempt percutaneous repair. More data are needed regard-
ng small access vessels and percutaneous repair as none of
he existing grafts are designed for use in access vessels 5
m in diameter. However, we have found that most arter-
es will tolerate this with a “Dotter” technique. Fig 6, a
hows a patient with small common femoral and external
liac arteries where the 7F sheaths are occlusive when intro-
uced into the arteries. Fig 6, b and c show widely patent
ommon femoral and external iliac arteries at the comple-
ion of the operation and the “Dotter” technique. We feel
hat small vessel size predicts failure because small diseased
FAs and external iliac arteries may not allow adequate
oom for proper function of the Perclose ProGlide device,
s the foot plate may not have adequate clearance for proper
unction without disrupting plaque or even suturing the
ack wall of the artery to the anterior wall. The instructions
or use of the Perclose ProGlide device state that “its
ffectiveness has not been evaluated in small femoral arter-
es 5 mm in diameter.”18 We feel that future improve-
ents in P-EVAR will be realized due to improvements in
ercutaneous closure devices rather than solely based on
ower-profile devices.
The technical success rate in our study reached 96%.
his compares favorably to the 76% to 96% success rates of
ther studies with 50 patients.3-7 Since 2007, we have
sed ultrasound scan guidance when performing all P-
VARs and the percutaneous failure rate per artery has
ecreased despite expanding P-EVAR to more patients and
maller-diameter arteries. Starnes et al7 demonstrated in a
tudy of 59 and 93 arteries accessed with and without
ltrasound, respectively, that ultrasound scan guidance sig-
ificantly decreased their conversion to open repair in
heaths 20F (0% vs 14%; P  .05) as well as significantly
ncreased their technical success rate in sheaths 20F
100% vs 82%; P  .05). In a study of 52 patients and 85
rteries by Og˘uzkurt et al,8 technical success was achieved
n 49 patients (94%) and there were no wound complica-
ions at the end of the case and at their 30-day follow-up
isit.
Femoral cutdown access for EVAR has complications
hat include wound infections, lymphoceles, and hemato-
as. These complications can occur after percutaneous
ccess as well. Morasch et al11 reported a wound complica-
ion rate of 22.8% in 35 patients who received femoral
s
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June 20121560 Bensley et alcutdown (three patients with femoral neuropathies, three
patients with lymphoceles, one patient with scrotal edema,
and one patient with wound infection) vs zero complica-
tions in 47 patients who received percutaneous access.
Dalainas et al,19 in a study of 186 patients undergoing
femoral cutdown for EVAR, reported an 8% wound infec-
tion rate and a 6.5% rate of wound necrosis and dehiscence.
There was no percutaneous comparison group. Our results
demonstrate that patients undergoing percutaneous access
have significantly fewer wound complications than those
undergoing femoral cutdown as well. One patient (0.6%) in
the P-EVAR group (hematoma) and seven patients (6.5%)
in the C-EVAR group (three wound infections, two hema-
tomas, one pseudoaneurysm, and one seroma) experienced
wound complications (P  .01). Although we did not see
an increase in wound complications with failed access, it is
intuitive that this may be the case. The operating room time
is longer with failed access and it would be best to avoid this
if failure could be accurately predicted. At this time, we do
not have any rigid criteria for cutdown; however, we would
likely perform a planned femoral cutdown for CFA occlu-
sion or in patients with an indication for femoral endarter-
ectomy independent of their aneurysm.
Several studies have demonstrated that morbid
obesity,6,7,11-15 large sheath size,11-13,15 and femoral artery
calcification10,15 are associated with failed percutaneous
access. Our study revealed no such findings. We looked at
obesity (BMI30) rather than morbid obesity (BMI35)
in our study and found that one obese patient experienced
failure (2.7%) vs 11 nonobese patients (8.7%), P  .22.
Interestingly, large sheath size (18-24F) was not associated
with percutaneous failure in our study. In fact, we found
the exact opposite. There was a significant increased risk of
percutaneous failure with small sheaths in our study (7.4%
vs 1.9%; P  .02). It is hard to draw any concrete conclu-
Fig 6. a, Angiogram showing a patient with small-dia
where the 7F sheaths are occlusive. b and c, Post endovas
blood flow through the common femoral and external ilia
abdominal aortic aneurysm (AAA) repair.sions from this other than to reiterate that even small Wheaths can cause serious complications when placed into
iseased arteries and care needs to be taken when perform-
ng percutaneous access. In fact, we use the smaller artery as
he contralateral side and deliver the main body through
he larger artery. We made no effort to quantify femoral
rtery calcification in this study and we do not exclude
atients with calcification from receiving percutaneous ac-
ess. With ultrasound scan guidance, we avoid heavily
alcified areas of the CFA when locating the best puncture
ite. Since 2005, we have only had two failures (of 13 total
ailures) attributed to femoral artery calcification.
Limitations to this study include its retrospective de-
ign. Certainly, earlier in the study period, there was a
election bias, as patients with small vessels and calcification
ere not offered percutaneous access. As virtually all pa-
ients who now undergo elective AAA repair are doing so
ia percutaneous access, the earlier selection bias has been
liminated. The low number of events can lend itself to
isinterpretation of the data as well as limit the amount of
ultivariable modeling one can perform.
ONCLUSIONS
P-EVAR can be performed in the vast majority of
atients using ultrasound scan guidance with a high success
ate, shorter operative times, and fewer wound complica-
ions. Access vessel diameters5 mm are at greater risk for
ercutaneous failure and should be treated selectively.
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